HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours

4th March 2026 Uncategorised 0

First‑in‑human phase 1/2a study launches in China and the US targeting advanced cancers

More: HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
Source: News